Scientists are working on a new test to predict colorectal cancer in IBD patients. South_agency/Getty Images Now, researchers from The Institute of Cancer Research in London have developed a new test ...

A closely watched therapy developed by Johnson & Johnson failed to show a statistically meaningful improvement for IBD ...

Inflammatory bowel disease (IBD), affecting an estimated 6–8 million people worldwide, may soon be monitored with a simple ...

Two biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease (IBD), but gastroenterologists are hoping to gain even more insight from ...

A new test can predict a high-risk patient's likelihood of developing bowel cancer in the next five years by 90%. Peakstock - stock.adobe.com A new DNA test developed in the UK can accurately predict ...

For the roughly 3 million Americans living with inflammatory bowel disease, the current treatment options tell a frustrating ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests. Scientists have developed a ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests. Scientists have developed a ...

IBD is an immune condition. Instead of peacefully coexisting with gut microbes, the immune system becomes overly reactive, ...

Picture this common clinical scenario: A patient has chronic diarrhea, abdominal pain, and weight loss. Blood and stool tests point to inflammatory bowel disease (IBD). But which one -- Crohn's ...

Past research shows that it can be challenging to detect pre-cancerous cells in people with IBD. Researchers from The Institute of Cancer Research in London have developed a new test that they report ...